Skip to main navigation Skip to search Skip to main content

Management okulärer Toxizität bei Mirvetuximab Soravtansine-Patientinnen.

Activity: Talk, presentation or poster › Scientific talk or presentation › On site

Period2025
Event titleFortbildung
Event typeOther
Degree of RecognitionNational